TRYAL

This brand name is authorized in Nigeria.

Active ingredients

The drug TRYAL contains one active pharmaceutical ingredient (API):

1	Estradiol UNII OKG364O896 - ESTRADIOL VALERATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100716	Tablet	TRYAL TABLETS TAB 2 mg 1 X 28	82 NF-PP-343312 TRYAL TABLETS ESTRADIOL VALERATE 2MG TABLETS ESTRADIOL VALERATE USP 2MG, MAIZE STARCH BP, LACTOSE BP,POVIDONE BP,MAGNESIUM STEARATE BP 2MG, SODIUM STARCH GLYCOLATE BP 2MG, TITANIUM DIOXIDE BP 1GM. A4-100716 Drugs Imported Products 128 POM 2 7/10/2023 IGNITE PHARMA NIGERIA LIMITED, 30, Ajegunle Village. Magboro, Ogun State. Nigeria 8034646146 ignitepharma18@gmail.com SYNOKEM PHARMACEUTICALS LIMITED, PLOT NO. 35-36, SECTOR: 6A, 1IE, SIDCUL, RANIPUR HARIDWAR-249 403, UTTARAKHAND, INDIA, India	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100716